BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 925959)

  • 1. Vesicular and juxtavesicular serotonin: effects of lysergic acid diethylamide and reserpine.
    Halaris AE; Freedman DX
    J Pharmacol Exp Ther; 1977 Dec; 203(3):575-86. PubMed ID: 925959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve terminal effects of indoleamine psychotomimetics on 5-hydroxytryptamine.
    Halaris AE
    Neurosci Biobehav Rev; 1982; 6(4):483-7. PubMed ID: 6294571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and ultrastructural maturation of serotonergic synapses during ontogeny.
    Tissari AH
    Med Biol; 1975 Feb; 53(1):1-14. PubMed ID: 1095838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chlorimipramine and lysergic acid diethylamide on efflux of precursor-formed 3-H-serotonin: correlations with serotonergic impulse flow.
    Gallager DW; Aghajanian GK
    J Pharmacol Exp Ther; 1975 Jun; 193(3):785-95. PubMed ID: 168347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats.
    Kuhn DM; Wolf WA; Youdim MB
    Br J Pharmacol; 1985 Jan; 84(1):121-9. PubMed ID: 2579697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LSD has high efficacy relative to serotonin in enhancing the cationic current Ih: intracellular studies in rat facial motoneurons.
    Garratt JC; Alreja M; Aghajanian GK
    Synapse; 1993 Feb; 13(2):123-34. PubMed ID: 8446921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain serotonin metabolism after tolerance dosage of LSD.
    Freedman DX; Boggan WO
    Adv Biochem Psychopharmacol; 1974; 10():151-7. PubMed ID: 4846536
    [No Abstract]   [Full Text] [Related]  

  • 8. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The raphe neuronal system and serotonergic effects of LSD.
    Halaris AE; Rosenthal M; DeMet EM; Freedman DX
    Neuropharmacology; 1982 Aug; 21(8):811-6. PubMed ID: 6181428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
    Langer SZ; Moret C
    J Pharmacol Exp Ther; 1982 Jul; 222(1):220-6. PubMed ID: 6953233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    Sanders-Bush E; Burris KD; Knoth K
    J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of lysergic acid derivatives and reserpine on 5-HT binding to nerve ending particles.
    Marchbanks RM
    Biochem Pharmacol; 1967 Oct; 16(10):1971-9. PubMed ID: 6065963
    [No Abstract]   [Full Text] [Related]  

  • 13. Participation of serotonin in development of morphine dependence in mice and rats.
    Kruszewska A
    Pol J Pharmacol Pharm; 1980; 32(5):655-63. PubMed ID: 6973754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Effect of LSD on rat brain 5-hydroxy-tryptamine metabolism at elevated environmental temperature.
    Curzon G; Marsden CA
    Br J Pharmacol; 1976 Mar; 56(3):368P-369P. PubMed ID: 1260198
    [No Abstract]   [Full Text] [Related]  

  • 16. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.
    Leysen JE
    J Physiol (Paris); 1981; 77(2-3):351-62. PubMed ID: 7288650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain.
    Blier P; de Montigny C
    Synapse; 1987; 1(5):470-80. PubMed ID: 2905533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptosomal uptake and release of dopamine and 5-hydroxy-tryptamine in the nucleus accumbens in vitro following in vivo administration of lysergic acid diethylamide in rats.
    Hetey L; Quiring K
    Acta Biol Med Ger; 1980; 39(8-9):889-95. PubMed ID: 7282218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.